Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2022 Mar 3:10:743138.
doi: 10.3389/fpubh.2022.743138. eCollection 2022.

Impact of Polypharmacy, Drug-Related Problems, and Potentially Inappropriate Medications in Geriatric Patients and Its Implications for Bulgaria-Narrative Review and Meta-Analysis

Affiliations
Meta-Analysis

Impact of Polypharmacy, Drug-Related Problems, and Potentially Inappropriate Medications in Geriatric Patients and Its Implications for Bulgaria-Narrative Review and Meta-Analysis

Tzvetan Krustev et al. Front Public Health. .

Abstract

Objective: Polypharmacy and inappropriate prescribing are overlooked issues in Bulgaria. We aimed at collecting and analyzing global literature on the most prevalent risk factors and investigating what they could reveal about current practice.

Materials and methods: A systematic narrative review and meta-analysis was conducted on the topic, investigating the prevalence of polypharmacy, odds of potentially inappropriate medications (PIMs) due to polypharmacy, and the likelihood of developing a drug-related problem (DRP) due to PIMs. The results were then related to current demographic statistics to estimate the potential impact on Bulgarian elderly patients.

Results: The prevalence of polypharmacy was estimated at 41% in elderly populations. The odds of a potentially inappropriate medication being prescribed were 2.095, with an expected 30.84% of those leading to a DRP. These numbers indicated that the expected Bulgarian elderly with polypharmacy should be 709,676 with 212,903 cases of DRPs.

Conclusion: Global polypharmacy rates seem to be on the rise, with an expected increase in DRPs.

Keywords: Bulgaria; drug-related problems; elderly patients; inappropriate prescribing; meta-analysis; polypharmacy.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
The PRISMA flow diagram of the work process.
Figure 2
Figure 2
Distribution of results and size of the effect regarding the risk of being prescribed a PIM with polypharmacy as a risk factor.
Figure 3
Figure 3
Meta-analysis and distribution of results regarding the risk of developing a DRP with a PIM present.
Figure 4
Figure 4
Age distribution of the Bulgarian population.
Figure 5
Figure 5
Percentage distribution of the population.

References

    1. Sergi G, De Rui M, Sarti S, Manzato E. Polypharmacy in the elderly: can comprehensive geriatric assessment reduce inappropriate medication use? Drugs Aging. (2011) 28:509–18. 10.2165/11592010-000000000-00000 - DOI - PubMed
    1. Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. (2017) 17:230. 10.1186/s12877-017-0621-2 - DOI - PMC - PubMed
    1. O'Dwyer M, Peklar J, McCallion P, McCarron M, Henman MC. Factors associated with polypharmacy and excessive polypharmacy in older people with intellectual disability differ from the general population: a cross-sectional observational nationwide study. BMJ Open. (2016) 6:e010505. 10.1136/bmjopen-2015-010505 - DOI - PMC - PubMed
    1. Salive ME. Multimorbidity in older adults. Epidemiol Rev. (2013) 35:75–83. 10.1093/epirev/mxs009 - DOI - PubMed
    1. Varghese D, Koya HH. Polypharmacy. StatPearls: (2020). Available online at: https://www.ncbi.nlm.nih.gov/books/NBK532953/ (accessed November 24, 2020).

LinkOut - more resources